Received Mar 24, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | UNK | X005044 | — |
No additional AE reported; dose of GARDASIl-9 expired on 1/2/2025 and was administered on 3/18/2025 to a 17-year-old female consumer; This spontaneous report was received from a physician assistant and refers to a 17-year-old female patient. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 18-Mar-2025, the patient was vaccinated with an expired dose of Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL 9) (dose, route, anatomical site, lot #X005044, expiration date: 02-Jan-2025) for prophylaxis (expired product administered). No additional adverse event was reported (no adverse event). Additional information is not expected.